Evidence map›Paper›PMID 42232803›Full record

ArticleCurrent research in parasitology & vector-borne diseases2026

Detection of suitable habitat areas in Japan of the Lyme disease and tick-borne encephalitis vectors

Patrick H Kelly, Harrison M Marick, Julie Davis, Ai Takano, Kentaro Yoshii, Hiroki Kawabata, Kentaro Itokawa, Kozue Sato, Alice C C Lau, Yongjin Qiu and 6 more

Abstract read
In one paragraph

Article in Current research in parasitology & vector-borne diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Patrick H KellyU.S. Medical Affairs, Vaccines, U.S. Commercial Division, Pfizer, Collegeville, PA, USA.
Harrison M MarickTiber Solutions, VA, USA.
Julie DavisGlobal Vaccines Medical Affairs, Pfizer Research & Development, Boston, MA, USA.
Ai TakanoDepartment of Veterinary Epidemiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Kentaro YoshiiNational Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Nagasaki, Japan.
Hiroki KawabataNational Institute of Infectious Diseases (NIID), Tokyo, Japan.
Kentaro ItokawaNational Institute of Infectious Diseases (NIID), Tokyo, Japan.
Kozue SatoNational Institute of Infectious Diseases (NIID), Tokyo, Japan.
Alice C C LauDepartment of Veterinary Epidemiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Yongjin QiuNational Institute of Infectious Diseases (NIID), Tokyo, Japan.
Andreas PilzGlobal Vaccines Medical Affairs, Pfizer Research & Development, Pfizer, Vienna, Austria.
Agustín Estrada-PeñaSenior External Consultant, Ministry of Health, Government of Spain, Madrid, Spain.
Frederick J AnguloU.S. Medical Affairs, Vaccines, U.S. Commercial Division, Pfizer, Collegeville, PA, USA.
Shuhei ItoVaccines Medical Affairs, Pfizer Japan, Tokyo, Japan.
Jennifer C MoïsiGlobal Vaccines Medical Affairs, Pfizer Research & Development, Paris, France.
Yoshikazu NakayamaVaccines Medical Affairs, Pfizer Japan, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Japan, Lyme disease and tick-borne encephalitis (TBE) are primarily in the northernmost prefecture Hokkaido, where their primary vectors

Indexed as

Borrelia burgdorferiIxodesIxodidJapanLyme diseaseTBETick;

Identifiers

PMID42232803
PMCPMC13223795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.